General Information of the Protein
Protein ID
PT01184
Protein Name
Rho-associated protein kinase 1
Secondarily
Protein Name
Renal carcinoma antigen NY-REN-35
Rho-associated
coiled-coil-containing protein kinase 1
Rho-associated
coiled-coil-containing protein kinase I
p160 ROCK-1
Gene Name
ROCK1
Sequence
MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
AGC protein kinase group
>
AGC protein kinase DMPK family
>
AGC protein kinase ROCK subfamily
Function
Protein kinase which is a key regulator of the actin cytoskeleton and cell polarity (PubMed:10436159, PubMed:10652353, PubMed:11018042, PubMed:11283607, PubMed:17158456, PubMed:18573880, PubMed:19131646, PubMed:8617235, PubMed:9722579). Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, TPPP, PFN1 and PPP1R12A (PubMed:10436159, PubMed:10652353, PubMed:11018042, PubMed:11283607, PubMed:17158456, PubMed:18573880, PubMed:19131646, PubMed:8617235, PubMed:9722579, PubMed:23093407, PubMed:23355470). Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing (PubMed:18694941). Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress (PubMed:19036714). Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability (By similarity). Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation (PubMed:19181962). Required for centrosome positioning and centrosome-dependent exit from mitosis (By similarity). Plays a role in terminal erythroid differentiation (PubMed:21072057). Inhibits podocyte motility via regulation of actin cytoskeletal dynamics and phosphorylation of CFL1 (By similarity). Promotes keratinocyte terminal differentiation (PubMed:19997641). Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (By similarity). May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
Q13464

Secondarily ID:
B0YJ91
Q2KHM4
Q59GZ4
    Show/Hide
Ensembl ID
ENSG00000067900
HGNC ID
HGNC:10251
Subcellular Location
Cytoplasm
Cytoplasm
Cytoskeleton
Microtubule organizing center
Centrosome
Centriole
Golgi apparatus membrane
Cell projection
Bleb
Cytoplasm
Cytoskeleton
Cell membrane
Cell projection
Lamellipodium
Cell projection
Ruffle
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000333 , GTM-3
Compound ID Compound Name Compound Formula
CP0333734
(+/-)-4-(5-(1-aminobutyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C17H20N4S
 1
1
EC50 = 600 nM
   TI
   LI
   LO
   TS
CP0060392
(R)-4-(1-aminoethyl)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide
   Show/Hide
C16H16N4O
 1
1
EC50 = 790 nM
   TI
   LI
   LO
   TS
CP0293496
(+/-)-3-(amino(2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yl)methyl)phenol
   Show/Hide
C20H18N4OS
 1
1
EC50 = 900 nM
   TI
   LI
   LO
   TS
CP0095525
3-(2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-ylamino)phenol
   Show/Hide
C19H16N4OS
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0038863
(+/-)-4-(5-(amino(phenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C20H18N4S
 1
1
EC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0146228
(+/-)-4-(5-(1-amino-3-methylbutyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C18H22N4S
 1
1
EC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0191216
(+/-)-4-(5-(1-aminopropyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C16H18N4S
 1
1
EC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0105393
(+/-)--4-(5-(amino(m-tolyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H20N4S
 1
1
EC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0317856
(+/-)-4-(5-(1-amino-2-methylpropyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C17H20N4S
 1
1
EC50 = 2100 nM
   TI
   LI
   LO
   TS
CP0114870
(+/-)--4-(5-(amino(4-methoxyphenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H20N4OS
 1
1
EC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0146224
(+/-)--4-(5-(amino(3-chlorophenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C20H17ClN4S
 1
1
EC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0105390
3-((2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yl)methyl)phenol
   Show/Hide
C20H17N3OS
 1
1
EC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0095526
(+/-)-4-(5-(amino(3-methoxyphenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H20N4OS
 1
1
EC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0146227
(+/-)-4-(5-(1-aminoethyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C15H16N4S
 1
1
EC50 = 4200 nM
   TI
   LI
   LO
   TS
CP0038854
4-(3-methyl-5-phenylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C19H15N3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0093642
4-(5-(3-methoxybenzyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H19N3OS
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0095519
4-(3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C13H11N3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0095524
3-((2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yl)methyl)benzoic acid
   Show/Hide
C21H17N3O2S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0146220
4-(5-(4-methoxybenzyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H19N3OS
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0146221
4-(3-methyl-5-(3-(trifluoromethyl)benzyl)benzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H16F3N3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0258963
4-(5-benzyl-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C20H17N3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0293498
4-(5-(aminomethyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C14H14N4S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0299314
4-(5-(2-methoxybenzyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H19N3OS
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0333731
methyl 3-[[2-(2-aminopyrimidin-4-yl)-3-methyl-1-benzothiophen-5-yl]methyl]benzoate
   Show/Hide
C22H19N3O2S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0333732
3-(2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yloxy)phenol
   Show/Hide
C19H15N3O2S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0357708
4-N-(2,3-dihydro-1H-inden-2-yl)-2-piperazin-1-yl-6-N-pyridin-4-ylpyrimidine-4,6-diamine
   Show/Hide
C22H25N7
 1
1 IC50 = 2 nM
CP0039567
2-N-(2,3-dihydro-1H-inden-2-yl)-6-piperazin-1-yl-4-N-pyridin-4-yl-1,3,5-triazine-2,4-diamine
   Show/Hide
C21H24N8
 1
1 IC50 = 6 nM
CP0230283
(R)-N2-(2,3-dihydro-1H-inden-2-yl)-6-(3-methylpiperazin-1-yl)-N4-(pyridin-4-yl)-1,3,5-triazine-2,4-diamine
   Show/Hide
C22H26N8
 1
1 IC50 = 8 nM
CP0303457
4-(2,3-dihydro-1H-inden-2-yloxy)-6-(piperazin-1-yl)-N-(pyridin-4-yl)-1,3,5-triazin-2-amine
   Show/Hide
C21H23N7O
 1
1 IC50 = 8 nM
CP0039477
4-[1-ethyl-7-(piperidin-4-yloxy)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine
   Show/Hide
C15H19N7O2
 1
1 IC50 = 8 nM
CP0293496
(+/-)-3-(amino(2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yl)methyl)phenol
   Show/Hide
C20H18N4OS
 1
1 IC50 = 10 nM
CP0271653
6-(1,4-diazepan-1-yl)-N2-(2,3-dihydro-1H-inden-2-yl)-N4-(pyridin-4-yl)-1,3,5-triazine-2,4-diamine
   Show/Hide
C22H26N8
 1
1 IC50 = 11 nM
CP0076849
4-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine
   Show/Hide
C10H10N6O
 1
1 IC50 = 13 nM
CP0191570
4-N-(2,3-dihydro-1H-inden-2-yl)-6-piperazin-1-yl-2-N-pyridin-4-ylpyrimidine-2,4-diamine
   Show/Hide
C22H25N7
 1
1 IC50 = 14 nM
CP0090990
[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-[(3S)-3-aminopyrrolidin-1-yl]methanone
   Show/Hide
C15H18N8O2
 1
1 IC50 = 14 nM
CP0285462
N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide
   Show/Hide
C21H16F4N4O2
 1
1 IC50 = 14 nM
CP0038863
(+/-)-4-(5-(amino(phenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C20H18N4S
 1
1 IC50 = 20 nM
CP0095525
3-(2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-ylamino)phenol
   Show/Hide
C19H16N4OS
 1
1 IC50 = 20 nM
CP0095526
(+/-)-4-(5-(amino(3-methoxyphenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H20N4OS
 1
1 IC50 = 20 nM
CP0105390
3-((2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yl)methyl)phenol
   Show/Hide
C20H17N3OS
 1
1 IC50 = 20 nM
CP0333734
(+/-)-4-(5-(1-aminobutyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C17H20N4S
 1
1 IC50 = 20 nM
CP0060392
(R)-4-(1-aminoethyl)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide
   Show/Hide
C16H16N4O
 3
1 IC50 = 30 nM
2 IC50 = 120 nM
3 Ki = 28 nM
CP0146224
(+/-)--4-(5-(amino(3-chlorophenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C20H17ClN4S
 1
1 IC50 = 30 nM
CP0146228
(+/-)-4-(5-(1-amino-3-methylbutyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C18H22N4S
 1
1 IC50 = 30 nM
CP0105393
(+/-)--4-(5-(amino(m-tolyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H20N4S
 1
1 IC50 = 50 nM
CP0095524
3-((2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yl)methyl)benzoic acid
   Show/Hide
C21H17N3O2S
 1
1 IC50 = 60 nM
CP0317856
(+/-)-4-(5-(1-amino-2-methylpropyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C17H20N4S
 1
1 IC50 = 60 nM
CP0053129
6-[(3S)-piperidin-3-yl]oxy-2H-isoquinolin-1-one
   Show/Hide
C14H16N2O2
 3
1 IC50 = 61.66 nM
2 IC50 = 251.19 nM
3 Ki = 2.512 nM
CP0114870
(+/-)--4-(5-(amino(4-methoxyphenyl)methyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H20N4OS
 1
1 IC50 = 90 nM
CP0016240
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE
   Show/Hide
C14H21N3O
 6
1 IC50 = 93 nM
2 IC50 = 870.96 nM
3 Ki = 25.12 nM
4 Ki = 140 nM
5 Ki = 150 nM
6 Ki = 220 nM
CP0025658
GSK-180736A
   Show/Hide
C19H16FN5O2
 1
1 IC50 = 100 nM
CP0191216
(+/-)-4-(5-(1-aminopropyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C16H18N4S
 1
1 IC50 = 140 nM
CP0231441
6-[(3S)-1-benzylpiperidin-3-yl]oxyisoquinoline
   Show/Hide
C21H22N2O
 1
1 IC50 = 169.82 nM
CP0093642
4-(5-(3-methoxybenzyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H19N3OS
 1
1 IC50 = 230 nM
CP0162590
6-[(3S)-1-benzylpiperidin-3-yl]oxyisoquinolin-1-amine
   Show/Hide
C21H23N3O
 1
1 IC50 = 239.88 nM
CP0015602
5-(1,4-diazepan-1-ylsulfonyl)isoquinoline
   Show/Hide
C14H17N3O2S
 7
1 IC50 = 260 nM
2 IC50 = 660 nM
3 IC50 = 940 nM
4 IC50 = 3162.28 nM
5 IC50 = 4300 nM
6 Ki = 100 nM
7 Ki = 530 nM
CP0333732
3-(2-(2-aminopyrimidin-4-yl)-3-methylbenzo[b]thiophen-5-yloxy)phenol
   Show/Hide
C19H15N3O2S
 1
1 IC50 = 360 nM
CP0146227
(+/-)-4-(5-(1-aminoethyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C15H16N4S
 1
1 IC50 = 400 nM
CP0258963
4-(5-benzyl-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C20H17N3S
 1
1 IC50 = 580 nM
CP0231442
5-(1,4-diazepan-1-ylsulfonyl)isoquinolin-1-amine
   Show/Hide
C14H18N4O2S
 3
1 IC50 = 758.58 nM
2 IC50 = 3162.28 nM
3 Ki = 34.67 nM
CP0039474
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3R)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
   Show/Hide
C21H27N7O3
 1
1 IC50 = 890 nM
CP0038781
6-[(3S)-piperidin-3-yl]oxyisoquinolin-1-amine
   Show/Hide
C14H17N3O
 2
1 IC50 = 2137.96 nM
2 Ki = 37.15 nM
CP0293498
4-(5-(aminomethyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C14H14N4S
 1
1 IC50 = 2200 nM
CP0095519
4-(3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C13H11N3S
 1
1 IC50 = 2900 nM
CP0038854
4-(3-methyl-5-phenylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C19H15N3S
 1
1 IC50 = 4200 nM
CP0146220
4-(5-(4-methoxybenzyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H19N3OS
 1
1 IC50 = 7200 nM
CP0146221
4-(3-methyl-5-(3-(trifluoromethyl)benzyl)benzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H16F3N3S
 1
1 IC50 = 8600 nM
CP0299314
4-(5-(2-methoxybenzyl)-3-methylbenzo[b]thiophen-2-yl)pyrimidin-2-amine
   Show/Hide
C21H19N3OS
 1
1 IC50 = 9700 nM
CP0333731
methyl 3-[[2-(2-aminopyrimidin-4-yl)-3-methyl-1-benzothiophen-5-yl]methyl]benzoate
   Show/Hide
C22H19N3O2S
 1
1 IC50 = 10000 nM
CP0041156
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
   Show/Hide
C21H27N7O3
 1
1 Kd = 280 nM
Clinical Information about the Protein
Target 1 ( Rho-associated protein kinase 1 (ROCK1) )
Target Type Successful Target
Disease 5 Target-related Diseases  5
1 Open-angle glaucoma [ICD-11: 9C61]
2 Pulmonary arterial hypertension [ICD-11: BB01.0]
3 Diabetic nephropathy [ICD-11: GB61.Z]
4 Inflammation [ICD-11: 1A00-CA43.1]
5 Pain [ICD-11: MG30-MG3Z]
Approved Drug(s) 1 Approved Drug  1
1 Netarsudil Approved
Open-angle glaucoma
Clinical Trial Drug(s) 3 Clinical Trial Drugs  3
1 H-1152 Phase 2
Pulmonary arterial hypertension
2 SAR-407899 Phase 2
Diabetic nephropathy
3 GSK269962A Clinical trial
Inflammation
Investigative Drug(s) 1 Investigative Drug  1
1 AS-1892802 Investigative
Pain